ALC Health appoints Healix International to provide global claims management and support

Apple AALC Health is delighted to announce that with effect from 1st January our claims handling for new and renewing customers will be carried out by Healix International, the award winning medical claims experts, under an exclusive and unique arrangement.

This is the culmination of many months of intensive research and discussion and is the logical next step in ALC Health’s mission to provide an unbeatable customer experience.

Healix maintain medically backed 24/7 and 365 capability via their centres in the UK, New Zealand and Singapore and together with ALC Health’s unique, benefit rich product set, will provide an industry leading solution.

At the same time, ALC Health are extending their commitment to AXA PPP International as their main underwriting partner, so continuing to provide the financial strength, integrity and stability necessary to ensure benefit delivery.

Sarah Jewell, CEO of ALC Health, commented, “Our Company has been built on an absolute dedication to customers, service and quality. We have enjoyed unprecedented growth and support from our customers and brokers and, as we continue on our journey, we are delighted that we can add a partner with the stature and reputation of Healix International to underline our continuing commitment to them.

We believe that by partnering with Healix International we will be providing the most customer focused claims handling service in the industry, with qualified medical personnel involved at the notification stage and proactive control and settlement throughout the process.

We will also shortly unveil further developments to help us shape an even better experience for more customers, with a new design philosophy to guide our new websites, enhancements to products and territories, and further innovations and partners – all with greater consistency, synergy and efficiency.

We want our brand to be synonymous with quality and our customers to expect and receive unrivalled service, and we will keep innovating to achieve our aim of becoming the best iPMI provider in the world.”

For further press information contact Stephen Godbold, Managing Director on +44 (0)1903 817970 or by e-mail to


A single blood test that screens for several cancers moves one step closer

Scientists are working to develop a test that will allow doctors to screen for multiple cancer types from a single blood sample.

All cancers produce compounds that end up in the bloodstream, so it is feasible that such blood markers could form the basis of a general screening test for many different forms of cancer.

Cancer cells often start shedding blood markers long before many of the signs and symptoms of tumors begin to emerge, so earlier diagnosis can generally mean treatment is more effective, which, in turn, improves survival.

Healthy bacteria might one day be used to treat obesity

Our genes influence whether we are fat or thin by shaping which types of microbes thrive in our gut, scientists are now suggesting.

A recent discovery is pointing towards healthy bacteria one day being used to treat obesity and by studying human twins, scientists have found a type of bacteria that was not only associated with being thin but also seemed to run in families.

When the researchers treated mice with a specific member of this bacterial family, isolated from the twin study, the animals gained less weight than mice that did not get this treatment.

They are now working to identify which genes seem to influence the presence of the bacteria and why it would have an effect on weight and hope to be able develop these findings to create a probiotic to regulate weight.